Current Cancer Drug Targets

Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)

Back

Become EABM
Become Reviewer



Meet Our Editorial Board Member free to download

Volume:18   Issue: 5
Pp: 401-401
M. Caraglia
DOI: 10.2174/156800961805180522071829



Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality free to download

Volume:18   Issue: 5
Pp: 402-404
Massimiliano Berretta and Raffaele Di Francia
DOI: 10.2174/156800961805180522072538



Cancer Targeted Therapy Strategy: The Pathologist’s Perspectives

Volume:18   Issue: 5
Pp: 410-420
Lara Alessandrini, Tiziana Perin, Shahin Kadare, Lino del Pup, Lorenzo Memeo, Agostino Steffan, Lorenzo Colarossi, Massimiliano Berretta, Paolo De Paoli and Vincenzo Canzonieri*
DOI: 10.2174/1568009618666171129145703




Metastatic Colorectal Cancer: Role of Target Therapies and Future Perspectives

Volume:18   Issue: 5
Pp: 421-429
Anna Nappi, Massimiliano Berretta, Carmela Romano, Salvatore Tafuto, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Chiara De Divitiis, Lara Alessandrini, Francesco Fiorica, Alessandro Ottaiano and Guglielmo Nasti*
DOI: 10.2174/1568009617666170209095143




The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration

Volume:18   Issue: 5
Pp: 430-441
Massimiliano Berretta*, Carmela Romano, Raffaele Di Francia, Chiara De Diviitis, Vincenzo Canzonieri, Michele Caraglia, Gaetano Facchini and Guglielmo Nasti
DOI: 10.2174/1568009617666170208162058




Melanoma Adjuvant Treatment: Current Insight and Clinical Features

Volume:18   Issue: 5
Pp: 442-456
Carmine D`Aniello, Francesco Perri, Giuseppina Della Vittoria Scarpati, Chiara Della Pepa, Salvatore Pisconti, Vincenzo Montesarchio, Nicolas Wernert, Mayra Rachele Zarone, Michele Caraglia, Gaetano Facchini*, Massimiliano Berretta and Carla Cavaliere
DOI: 10.2174/1568009617666170208163714




Optimal Management of Prostate Cancer Based on its Natural Clinical History

Volume:18   Issue: 5
Pp: 457-467
Gaetano Facchini*, Francesco Perri, Gabriella Misso, Carmine D`Aniello, Giuseppina Della Vittoria Scarpati, Sabrina Rossetti, Chiara Della Pepa, Salvatore Pisconti, Gerhard Unteregger, Alessia Cossu, Michele Caraglia, Massimiliano Berretta and Carla Cavaliere
DOI: 10.2174/1568009617666170209093101




Current and Emerging Treatments for Metastatic Renal Cell Carcinoma

Volume:18   Issue: 5
Pp: 468-479
Carla Cavaliere, Carmine D`Aniello, Chiara Della Pepa, Salvatore Pisconti, Massimiliano Berretta and Gaetano Facchini*
DOI: 10.2174/1568009617666170209094030



The Real Impact of Target Therapy in Breast Cancer Patients: Between Hope and Reality

Volume:18   Issue: 5
Pp: 480-498
Sebastiano Bordonaro, Massimiliano Berretta, Antonino Carmelo Tralongo, Silvia Clementi, Brigida Stanzione and Paolo Tralongo*
DOI: 10.2174/1568009617666170209100322




Pharmacological Profile and Pharmacogenomics of Anti-Cancer Drugs Used for Targeted Therapy

Volume:18   Issue: 5
Pp: 499-511
Raffaele Di Francia*, Angela De Monaco, Mariangela Saggese, Giancarla Iaccarino, Stefania Crisci, Ferdinando Frigeri, Rosaria De Filippi, Massimiliano Berretta and Antonio Pinto
DOI: 10.2174/1568009617666170208162841